Drugs / MVA-SIBP
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07253675 | Dec 2025 → Feb 2027 expected | monkeypox | Shanghai Institute Of Biological Products | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MVA-SIBP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07253675 ↗ |
| Modality | Vaccine | “low dose monkeypox vaccine produced by Shanghai Institute of Biological Products Co., Ltd. (SIBP)” NCT07253675 ↗ |
| Route | Subcutaneous | “one subcutaneous dose” NCT07253675 ↗ |